NASDAQ •
Healthcare •
Health Information Services •
Quote as of 09/04/2026
Company Profile
IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization423.74 mln
Float10.23 mln
Earnings Date11/05/2026
Beneish M-Score
-2.37
Borderline
Relative Strength
26
/ 100
Underperforming
Debt / Equity
0.26
Very low leverage
Pre-Tax Margin
-57%
Severely loss-making
ROE
-60.79
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Carlsmed is a California-based medical technology company that uses artificial intelligence to create personalized solutions for spinal fusion surgery. Its core product, the aprevo platform, combines smart surgical planning software with custom-built implants shaped to fit each patient's unique anatomy. The software draws on real-world outcome data to help surgeons make better decisions before and during procedures. Founded in 2018 and headquartered in Carlsbad, the company is already selling its technology commercially.
